Literature DB >> 22263797

The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Tao Shen1, Shile Huang.   

Abstract

Cell division cycle 25 A (Cdc25A), a dual-specificity protein phosphatase, is one of the most crucial cell cycle regulators, which removes the inhibitory phosphorylation in cyclin-dependent kinases (CDKs), such as CDK2, CDK4, and CDK6, and positively regulates the activities of CDKs that lead to cell cycle progression. In addition, Cdc25A also acts as a regulator of apoptosis. Overexpression of Cdc25A promotes tumorigenesis, and is frequently observed in various types of cancer. Here we briefly summarize current understanding of the role of Cdc25A in cell proliferation and apoptosis, as well as the impact of overexpression of Cdc25A on tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263797      PMCID: PMC3544488          DOI: 10.2174/187152012800617678

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  126 in total

Review 1.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

2.  Dual mode of degradation of Cdc25 A phosphatase.

Authors:  Maddalena Donzelli; Massimo Squatrito; Dvora Ganoth; Avram Hershko; Michele Pagano; Giulio F Draetta
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 3.  Cdc25: mechanisms of checkpoint inhibition and recovery.

Authors:  Christina Karlsson-Rosenthal; Jonathan B A Millar
Journal:  Trends Cell Biol       Date:  2006-05-08       Impact factor: 20.808

4.  Multimodal control of Cdc25A by nitrosative stress.

Authors:  Robert J Tomko; John S Lazo
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

5.  Rapid destruction of human Cdc25A in response to DNA damage.

Authors:  N Mailand; J Falck; C Lukas; R G Syljuâsen; M Welcker; J Bartek; J Lukas
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

6.  Regulation of lung cancer cell growth and invasiveness by beta-TRCP.

Authors:  Nonggao He; Chengxin Li; Xiaoli Zhang; Tao Sheng; Sumin Chi; Kai Chen; Qian Wang; Roger Vertrees; Roberto Logrono; Jingwu Xie
Journal:  Mol Carcinog       Date:  2005-01       Impact factor: 4.784

7.  Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.

Authors:  Xundi Xu; Hirofumi Yamamoto; Masato Sakon; Masayoshi Yasui; Chew Yee Ngan; Hiroki Fukunaga; Tetsushi Morita; Minoru Ogawa; Hiroaki Nagano; Shoji Nakamori; Mitsugu Sekimoto; Nariaki Matsuura; Morito Monden
Journal:  Clin Cancer Res       Date:  2003-05       Impact factor: 12.531

8.  p53 polymorphisms and haplotypes in breast cancer.

Authors:  A Själander; R Birgander; G Hallmans; S Cajander; P Lenner; L Athlin; G Beckman; L Beckman
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

Review 9.  The decision to enter mitosis: feedback and redundancy in the mitotic entry network.

Authors:  Arne Lindqvist; Verónica Rodríguez-Bravo; René H Medema
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

10.  Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.

Authors:  I Hoffmann; G Draetta; E Karsenti
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more
  62 in total

1.  CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Authors:  C Dozier; L Mazzolini; C Cénac; C Froment; O Burlet-Schiltz; A Besson; S Manenti
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

Review 2.  Understanding the marvels behind liver regeneration.

Authors:  Anan Abu Rmilah; Wei Zhou; Erek Nelson; Li Lin; Bruce Amiot; Scott L Nyberg
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-03-28       Impact factor: 5.814

3.  MicroRNA-215 Regulates Fibroblast Function: Insights from a Human Fibrotic Disease.

Authors:  Wanwen Lan; Silin Chen; Louis Tong
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Altered miRNA expression in aniline-mediated cell cycle progression in rat spleen.

Authors:  Gangduo Wang; Jianling Wang; M Firoze Khan
Journal:  Toxicol Mech Methods       Date:  2017-06-06       Impact factor: 2.987

Review 5.  Progress with palbociclib in breast cancer: latest evidence and clinical considerations.

Authors:  Andrea Rocca; Alessio Schirone; Roberta Maltoni; Sara Bravaccini; Lorenzo Cecconetto; Alberto Farolfi; Giuseppe Bronte; Daniele Andreis
Journal:  Ther Adv Med Oncol       Date:  2016-11-21       Impact factor: 8.168

6.  Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway.

Authors:  Lin Li; Bei-bei Zheng; Li-sha Ma; Xiao Sun; Juan-juan Chang; Wei-Dong Xie; Xia Li
Journal:  Acta Pharmacol Sin       Date:  2014-09-01       Impact factor: 6.150

7.  Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.

Authors:  Yunying Zhou; Qishu Zhang; Ge Gao; Xiaoli Zhang; Yafei Liu; Shoudao Yuan; Xiaowei Wang; Jason J Chen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

8.  Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties.

Authors:  Thomas Bertero; Isabelle Bourget-Ponzio; Alexandre Puissant; Agnès Loubat; Bernard Mari; Guerrino Meneguzzi; Patrick Auberger; Pascal Barbry; Gilles Ponzio; Roger Rezzonico
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

Review 9.  Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.

Authors:  Swastika Sur; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-04-02       Impact factor: 3.396

10.  LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway.

Authors:  Shibin Qu; Kunwei Niu; Jianlin Wang; Jimin Dai; Anutosh Ganguly; Chao Gao; Yuzi Tian; Zhibin Lin; Xisheng Yang; Xuan Zhang; Zhengcai Liu; Haimin Li
Journal:  Cancer Gene Ther       Date:  2020-08-15       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.